Who We Are

We at SAI Parenteral's Limited are a pharmaceutical company established with a clear purpose: to manufacture quality medicines with consistency, discipline, and long-term reliability. Over the years, we have evolved from a manufacturing-focused operation into a diversified formulations company that integrates research, development, and commercial-scale production.

Our business is organised around two complementary verticals. Through our branded generics portfolio, we serve a wide domestic market with established formulations across multiple therapeutic areas. In parallel, our Contract Development and Manufacturing Organisation (CDMO) services enable us to partner with pharmaceutical companies and support them across the product lifecycle, from development to commercial manufacturing.

Our product portfolio spans cardiovascular care, neuropsychiatry, anti-diabetic therapy, respiratory health, antibiotics, gastroenterology, vitamins, minerals and supplements, analgesics, dermatology, and other related segments. We manufacture a range of dosage forms, including injectables, tablets, capsules, liquid orals, and ointments.

A defining feature of our journey has been the steady growth of our export business. By investing early in quality systems and regulatory compliance, we have built credibility in international markets. Our TGA-approved manufacturing facility represents a significant milestone in this journey.

At SAI Parenteral's, our growth philosophy is centred on scaling responsibly without compromising on quality. We focus on building long-term relationships with customers and partners, supported by consistent execution, regulatory discipline, and a commitment to doing things the right way.